Skip to main content
IMS Events Main banner

    Lisa B. Leypoldt, MD (she/her/hers)

    Clinician Scientist
    University Medical Center Hamburg-Eppendorf, Germany
    Hamburg, Germany

    Dr. Lisa Leypoldt, MD, is a clinician and researcher specializing in hematology/oncology and internal medicine at the Department of Oncology, Hematology and Bone Marrow Transplantation with Department of Pneumology, University Medical Center Hamburg-Eppendorf in Hamburg, Germany.

    Dr. Leypoldt received her medical degree from University of Hamburg after having trained in Hamburg, Münster, and Salt Lake City, UT, USA. Her research, as well as her clinical work, focuses in particular on multiple myeloma and related plasma cell dyscrasias. She is co-principal investigator in academic investigator-initiated clinical trials including the GMMG-CONCEPT trial for high-risk myeloma. From 2022-2024, she worked in the Medical Oncology laboratory of Constantine Mitsiades at Dana Farber Cancer Institute, Harvard Medical School in Boston, MA, USA, as a recipient of the Mildred-Scheel-Postdoctoral Scholarship by German Cancer Aid. Dr. Leypoldt has published research articles in high-ranking scientific journals and was awarded several prizes, most recently the Paul Martini Young Researcher Award 2024 and a Conquer Cancer Award (ASCO) 2025.

    Disclosure information not submitted.

    Presentation(s):